جست‌وجوی استاد و پژوهشگر

• Epidemiology of Birth Defects
• Gene-Environment Interactions in Perinatal Health
• Nutrition and Reproductive Outcomes
• +۴ مورد دیگر

Gary M. Shaw is the Rosemarie Hess Professor and Professor (Research) at Stanford University , with courtesy appointments in the Department of Epidemiology and Population Health and Department of Obstetrics & Gynecology - Maternal Fetal Medicine . He serves as Co-PI of the March of Dimes Prematurity Research Center at Stanford and PI of the California Center for Finding Causes and Preventives of Birth Defects . His research focuses on the Epidemiology of birth defects Gene-environment interactions in perinatal outcomes Nutritional factors in reproductive health . He has developed machine learning approaches for precision parenteral nutrition and predictive models for preterm birth, while investigating persistent metabolomic signatures following hypertensive pregnancy disorders. Shaw's recent work explores Climate change impacts on reproductive health Maternal-fetal immune interactions Epigenetic mechanisms in perinatal disease with applications of multiomics to neonatal intensive care units. As a member of Bio-X and the Maternal & Child Health Research Institute , he contributes to translational research networks while serving as Associate Editor for Birth Defects Research and American Journal of Medical Genetics . He supervises Med Scholar Project student Richard Liang Doctoral co-advisor for Saskia Comess and Richard Liang Master's advisor for Lenae Joe while leading the Division of Neonatology as Associate Chair for Clinical Research (2012-2025). His laboratory work integrates Metabolomic profiling Proteomic analysis Computational modeling Machine learning for biomedical data to advance neonatal care through precision medicine approaches.

• Chronic Obstructive Pulmonary Disease (COPD)
• Respiratory Medicine
• Asthma
• +۴ مورد دیگر

Per Sigvald Bakke is a Professor at the University of Bergen's Faculty of Medicine, Department of Clinical Science, with extensive expertise in respiratory medicine. His research primarily focuses on Chronic Obstructive Pulmonary Disease (COPD), asthma, and related pulmonary conditions, with significant contributions to understanding disease mechanisms, clinical phenotyping, and epidemiology. Dr. Bakke's research interests span COPD phenotyping, asthma heterogeneity, genomics of respiratory diseases, pulmonary function testing, and clinical epidemiology. His work frequently involves large-scale cohort studies and international collaborations, particularly through the U-BIOPRED consortium. His research has significantly advanced understanding of COPD progression, exacerbation risk factors, and the relationship between respiratory diseases and systemic conditions like metabolic syndrome. His publication record demonstrates consistent contributions to respiratory medicine, with recent work focusing on multi-omics approaches to disease phenotyping, genetic determinants of lung function, and clinical management of COPD. His research often bridges basic science with clinical application, addressing critical questions in respiratory disease management and patient outcomes. Dr. Bakke has been instrumental in numerous international collaborative studies including the ECLIPSE cohort, U-BIOPRED, and various genome-wide association studies examining COPD and asthma. His work has contributed to clinical guidelines and improved understanding of respiratory disease mechanisms across diverse populations.

Ole Andreas Andreassenمشاهده پروفایل

استاد

• Mental Disorders
• Neuropsychiatric Disorders
• Genetics
• +۶ مورد دیگر

Ole Andreas Andreassen is a Professor of Psychiatry and Director of the Centre for Precision Psychiatry at the University of Oslo. He holds a joint appointment as an Attending Psychiatrist (20%) at Oslo University Hospital. His academic career includes leadership roles such as Director of the Centre of Excellence NORMENT (2013–2023) and the KG Jebsen Centre for Psychosis Research (2012–2018). He completed his MD (1993) and PhD (1996) at the University of Bergen, followed by postdoctoral training at Harvard Medical School and Massachusetts General Hospital. Education: MD (1993, University of Bergen), PhD (1996, University of Bergen) Postdoc: Harvard Medical School (1998–2000) Specialist in Psychiatry: Oslo University Hospital (2006) His research focuses on mental and neuropsychiatric disorders, emphasizing genetics, brain imaging, and precision medicine. Key areas include the interplay of genetic and environmental factors in schizophrenia, bipolar disorder, and Alzheimer’s disease. He has pioneered studies on predictive tools and clinical interventions, with a strong emphasis on genomic and neuroimaging biomarkers. His publications span over 10 years, addressing topics like cortical abnormalities in bipolar disorder, genetic overlap between psychiatric conditions, and cannabis use impacts. These works highlight interdisciplinary approaches, blending genetics, neuroimaging, and clinical data. Awards: Brain Council Award (2024), Fridtjof Nansen Award (2023), University of Oslo Research Prize (2020) Leadership: Co-Director of the KG Jebsen Centre for Neurodevelopmental Disorders, ENIGMA Bipolar Working Group Chair, and member of the Psychiatric Genomics Consortium. Andreassen has supervised 42 PhD students and co-supervised numerous postdoctoral researchers. His grants and collaborations span EU-funded initiatives (e.g., CoMorMent, RealMent) and global networks like the Precision Psychiatry consortium. Labs and teams include the Centre for Precision Psychiatry and the Scandinavian Collaboration for Psychiatric Etiology (SCOPE), focusing on translational research and multimodal data integration.

Rachel Melamedمشاهده پروفایل

استادیار

• Computational Biology
• Cancer Genomics
• Data Science
• +۳ مورد دیگر

Rachel Melamed is an Assistant Professor of Biology at the University of Massachusetts Lowell, affiliated with the Kennedy College of Sciences and the Center of Biomedical and Health Research in Data Sciences (CHORDS). Her research focuses on linking health and molecular data to understand disease mechanisms and identify interventions for conditions like cancer. She employs computational methods from computer science and epidemiology, integrating diverse datasets including health records, biobanks, and drug experiments. Education: BA in Computer Science (Brown University), PhD in Biomedical Informatics (Columbia University), Postdoctoral training in Biomedical Data Science (University of Chicago). Research Interests: Disease biology & genomics, data science, epidemiology, causal inference. Projects include studying drug impacts on cancer pathways, genetic overlaps between diseases, and leveraging big data for personalized medicine. She leads a lab with graduate and undergraduate researchers exploring computational biology, bioinformatics, and pharmacology. Lab Team: Supervises students specializing in computational biology, statistics, and machine learning. Current members include Anugrah Vaishnav, Jianfeng Ke, Panagiotis Lalagkas, and others. Past researchers include Aylinh Eng and Bishoy Sargius. Key Focus Areas: Cancer etiology, drug repurposing, genetic risk stratification, and translational bioinformatics. Her work bridges computational methods with clinical and biological datasets to uncover actionable insights in disease prevention and treatment.

Nils Eiel Steenمشاهده پروفایل

استاد

• Psychiatric Genetics
• Immune Biomarkers in Mental Illness
• Neuroinflammation
• +۳ مورد دیگر

Nils Eiel Steen is a Professor at the Centre for Precision Psychiatry , Faculty of Medicine, University of Oslo . With a focus on psychiatric genetics and immune biomarkers , his work bridges schizophrenia research , bipolar disorder , and metabolic psychiatry . Genetic overlap between mental disorders and immune/metabolic traits Neuroinflammatory mechanisms in psychosis Neuroimaging-genetics integration Sex-specific pharmacological responses His recent publications reveal trends in: Linking cerebellar morphology to mental illnesses Mapping inflammatory-cognitive subgroups Identifying genetic pleiotropy across psychiatric and neurological conditions Elucidating infectious triggers in severe mental disorders Collaborations span Oslo University Hospital units and international consortia, with emphasis on translational neuroscience and precision medicine .

Gary E. Martinمشاهده پروفایل

دانشیار

• Speech-Language Pathology
• Autism Spectrum Disorder
• Fragile X Syndrome
• +۶ مورد دیگر

Gary E. Martin is an Associate Professor and Undergraduate Program Coordinator in the Department of Communication Sciences and Disorders (CSD) at St. John's College of Liberal Arts and Sciences, St. John's University. He also serves as Director of the MA Speech Language Pathology Program and Chair of the Task Force on Diversity, Equity, Inclusion, and Accessibility in CSD since 2020. Dr. Martin earned his educational credentials as follows: Ph.D. in Speech and Hearing Sciences from the University of North Carolina at Chapel Hill M.A. in Speech-Language Pathology from the University of Pittsburgh B.A. in Communication Sciences and Disorders from the University of Pittsburgh Dr. Martin's research focuses on speech and language development in children with neurodevelopmental disorders, particularly fragile X syndrome (FXS), autism spectrum disorder (ASD), and Down syndrome. His work emphasizes pragmatic language, prosody, and the overlap between FXS and ASD, with a growing focus on addressing the underrepresentation of marginalized groups in this research. His investigations often involve longitudinal studies examining communication across contexts and developmental trajectories. Analysis of Dr. Martin's recent publications reveals a strong emphasis on understanding language processing, narrative ability, and social communication in neurodevelopmental disorders. His research frequently employs multimethod approaches, examining both behavioral and neural aspects of communication. A notable trend is his work on familial patterns of language characteristics, exploring how traits manifest in first-degree relatives of individuals with autism. Dr. Martin is an active member of several professional organizations: American Speech-Language-Hearing Association (ASHA) International Society for Autism Research (INSAR) American Association of Intellectual and Developmental Disabilities (AAIDD) National Black Association for Speech-Language and Hearing (NBASLH) Dr. Martin has secured significant research funding, including roles as Consultant on National Institute on Deafness and Other Communication Disorders (R01) and National Institute of Mental Health (R01) grants. His research has resulted in 46 publications and over 130 presentations. He mentors students in the Speech-Language Pathology program and contributes to professional development through his leadership roles. Dr. Martin's work is conducted in collaboration with researchers at Northwestern University and other institutions, particularly through the ongoing family-genetic studies of language in autism and fragile X syndrome. His research team employs diverse methodologies including longitudinal assessments, acoustic analyses, and neural processing measurements to understand communication differences in neurodevelopmental conditions.

Ames Sutton Hickeyمشاهده پروفایل

استادیار

• Neurobiology
• Feeding Behavior
• Eating Disorders
• +۵ مورد دیگر

Dr. Ames Sutton Hickey is an Assistant Professor in the Department of Psychology and Neuroscience at Temple University's College of Liberal Arts. Her research focuses on the neurobiological mechanisms underlying feeding behavior and eating disorders, with particular emphasis on neural circuits in the hypothalamus. She employs genetic and behavioral rodent models combined with systems neuroscience techniques to investigate how neural circuits contribute to susceptibility to under- or over-nutrition. Dr. Hickey holds a PhD in Molecular and Integrative Physiology from the University of Michigan, where she was mentored by Dr. David Olson and Dr. Martin Myers Jr. She completed postdoctoral training under Dr. Kay Tye at MIT and Dr. Michael Krashes at the NIH/NIDDK, focusing on how food deprivation alters neural circuits and behavior. Her lab (The ASH Lab) is opening in January 2023 and will continue this line of research. Her work bridges neurobiology and clinical applications, addressing poorly understood areas such as the overlap in neural circuits between anorexia and obesity. Key contributions include studies on AgRP neurons, melanocortin receptor-expressing neurons, and novel tools for measuring rodent behavior. Her research highlights the importance of systems-level approaches in understanding complex feeding behaviors and their dysregulation in disease. Dr. Hickey’s lab emphasizes translational research, aiming to identify neural pathways that could inform treatments for eating disorders and metabolic disorders. She collaborates on open-source instrumentation development for behavioral studies, exemplified by the FED3 device for home-cage monitoring of food intake.

Theodore G. Drivasمشاهده پروفایل

استادیار

• Genetic Medicine
• Genomics
• Human Genetics
• +۳ مورد دیگر

Theodore G. Drivas, MD, PhD is an Assistant Professor of Medicine at the University of Pennsylvania's Perelman School of Medicine. His research focuses on the genetic architecture of human disease, particularly examining interactions between common and rare genetic variants and their relationship to common and rare diseases. Academic Rank: Assistant Professor Institution: University of Pennsylvania School: Perelman School of Medicine Department: Department of Medicine Dr. Drivas's work spans multiple domains including: Genetic Medicine Genomics Human Genetics Precision Medicine Clinical Genetics Health Disparities Recent research trends show strong emphasis on: GWAS studies for inflammatory diseases like hidradenitis suppurativa Racial disparities in genetic testing access Polygenic risk score validation and implementation Multi-ethnic cancer susceptibility gene analysis Sex-specific genetic effects in cardiomyopathy Development of genomic implementation strategies

Mikkel Wallentinمشاهده پروفایل

استاد

• Psycholinguistics
• Neurolinguistics
• Cognitive Neuroscience
• +۱۲ مورد دیگر

Mikkel Wallentin is a Professor at the School of Communication and Culture, Aarhus University, specializing in Cognitive Science. He investigates the intricate relationships between language, brain, and cognition through interdisciplinary research combining neuroscience, linguistics, and psychology. His research interests include psycholinguistics, neurolinguistics, neuropragmatics, spatial memory, language comprehension, and inner speech . He employs methods such as fMRI, behavioral experiments, and corpus analysis to explore how cognitive processes are embodied in linguistic behavior. His work also touches on gender differences in language development, depression detection via lexical choice, and aging in spatial communication. Wallentin's recent publications reveal a strong focus on emotional inner speech, its physiological effects, and its role in self-regulation , alongside studies on early language acquisition and linguistic pragmatics. His work bridges theoretical linguistics with cognitive neuroscience, often involving cross-linguistic and clinical populations. Principal Investigator, SCALA: Spatial Communication and Ageing across Languages (2024–2028) Participant, Cognition, Language and Music (2009–2013) Participant, Mass Experiment 2016 He has been actively involved in public dissemination, delivering lectures such as 'Language: A Window into the Mind' and contributing to media on topics like julefilm psychology and developmental language disorders. With over 127 research outputs, he maintains a robust scholarly presence in cognitive science.

Patrick Sullivanمشاهده پروفایل

استاد

• Psychiatric Genetics
• Schizophrenia
• Major Depressive Disorder
• +۳ مورد دیگر

Patrick Sullivan, MD, is the Ray M. Hayworth & Family Distinguished Professor of Psychiatry and Professor of Genetics at the University of North Carolina (UNC) Chapel Hill, and a Professor at Karolinska Institutet in Sweden. He leads the Center for Psychiatric Genomics and co-founded the Psychiatric Genomics Consortium. His research focuses on the genetic basis of psychiatric disorders such as schizophrenia, major depressive disorder, post-partum depression, and eating disorders, employing molecular genetics, epidemiology, and large-scale consortia. Sullivan has trained numerous post-doctoral researchers and maintains a lab with significant NIH and international funding. Education: MD, University of California, San Francisco BS in Biology, University of Notre Dame Research Interests: The Sullivan Lab integrates genetic, epidemiological, and clinical approaches to understand complex psychiatric disorders. Key areas include identifying genetic variants influencing disease etiology, pharmacogenetics of antipsychotics, and leveraging multi-country consortia to study shared genetic mechanisms across disorders. The lab emphasizes translational research to bridge genetic findings with clinical applications. Publications & Awards: Sullivan has over 400 peer-reviewed publications (h-index 114) and received the Ming Tsuang Lifetime Achievement Award. Recent work highlights shared genetic variants across eight psychiatric disorders and the role of mitochondrial dysregulation in schizophrenia. Grants & Collaborations: Primary funders include the NIH and Swedish Research Council. Sullivan splits time between UNC and Karolinska Institutet, fostering international collaborations. His lab engages in global initiatives like the Nordic OCD & Related Disorders Consortium and the Eating Disorders Genetics Initiative. Labs & Teams: Based in UNC’s School of Medicine and Karolinska’s Psychiatric Genomics Institute. Collaborations span epidemiology, biostatistics, and computational biology. Key lab members include Dr. Jin Szatkiewicz (copy number variation in schizophrenia), Dr. Jim Crowley (obsessive-compulsive disorder genetics), and project manager Dr. NaEshia Ancalade.

Doo-Sup Choiمشاهده پروفایل

استاد

• Neurobehavioral Disorders
• Addictive Disorders
• Neurobiology of Addiction
• +۱۸ مورد دیگر

Doo-Sup Choi, Ph.D. , is a Professor of Pharmacology and Psychiatry at Mayo Clinic in Rochester, Minnesota. He serves as a Consultant in the Department of Molecular Pharmacology and Experimental Therapeutics and leads the Neurobiology of Alcoholism and Drug Addiction Laboratory. Dr. Choi is also the Director of the Samuel C. Johnson Genomics of Addiction Program, a multidisciplinary initiative integrating basic and clinical research to translate findings into patient care. His research focuses on identifying novel therapeutic targets for neurobehavioral and addictive disorders using advanced techniques in genetics, pharmacology, proteomics, metabolomics, neuroimaging, and behavioral analysis. Key areas include the neurobiology of addiction, co-occurring psychiatric disorders such as depression and anxiety, and the interaction between alcohol use disorder and neurodegenerative conditions like Alzheimer's disease. Dr. Choi's recent publications highlight a strong trend in translational neuroscience, with a focus on biomarker development, purinergic signaling, astrocyte-neuron interactions, and the impact of alcohol on aging and cognition. His work increasingly bridges molecular mechanisms with clinical applications, emphasizing personalized treatment strategies. David Lehr Research Award, American Society for Pharmacology and Experimental Therapeutics (2015) Dr. Choi has been actively involved in mentoring and collaborative research, serving as a full member of the American College of Neuropsychopharmacology and as a regular member of the National Institute on Alcohol Abuse and Alcoholism review subcommittee (2016–2020). His lab has been continuously funded by the NIH and other external sources since its founding in 2005. The Neurobiology of Alcoholism and Drug Addiction Lab employs cutting-edge technologies such as optogenetics, chemogenetics, fiber photometry, and computational modeling to study neural circuits underlying addictive behaviors.

Sarah Bergenمشاهده پروفایل

مدرس ارشد

• Psychiatric Genetic Epidemiology
• Schizophrenia Research
• Bipolar Disorder Research
• +۷ مورد دیگر

Sarah Bergen is a Senior Lecturer and Docent at the Department of Medical Epidemiology and Biostatistics at Karolinska Institutet. She leads the Psychiatric Genetic Epidemiology research group, focusing on understanding the biological and environmental foundations of psychiatric disorders and their comorbidities with other medical conditions. Her educational background includes: Docent, Karolinska Institutet, 2014 PhD in Human and Molecular Genetics, Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, 2009 MS in Neuroscience, University of Pittsburgh, 2004 BA in Neuroscience and Psychology, Macalester College, 2000 Dr. Bergen conducts quantitative genetics research predominantly focusing on schizophrenia and bipolar disorder, as well as depression and eating disorders. Her current studies aim to better understand the genetic and environmental contributions to disease risk, comorbidities associated with these disorders, and the observed variability within patient groups. She has a strong foundation in neuroscience which offers added biological context to the results from genetic research studies. Her research group investigates genetic and environmental risk factors for psychiatric disorders, epidemiological and genetic relationships between different psychiatric disorders, and relationships between psychiatric disorders and comorbid medical conditions. Her recent publications demonstrate a strong emphasis on genetic overlap between psychiatric disorders and other medical conditions, environmental risk factors across the lifespan, and subtyping approaches to understand heterogeneous etiological pathways. Her work frequently utilizes large population-based datasets from Sweden and employs advanced genetic epidemiological methods. Dr. Bergen serves as Director of studies for the KI-NIH Doctoral Program in Neuroscience and has held various leadership positions including on the Management Committee for Maximizing Impact of research in NeuroDevelopmental DisorderS (MINDDS) and Enhancing psychiatric genetic counselling, testing, and training in Europe (EnGagE). She has also served on the Board of Directors for the International Society for Psychiatric Genetics (ISPG). She leads the Psychiatric Genetic Epidemiology research group at Karolinska Institutet, which aims to discover the biological and environmental foundations of psychiatric disorders, the patterns and determinants of their comorbidities with other medical disorders, and subgroups within psychiatric patient populations. The group's ultimate goal is to contribute to improved treatment options and help alleviate the personal and social burdens associated with these disorders.

Nadine Octavia Patricia Parkerمشاهده پروفایل

پژوهشگر

• Psychiatric Genetics
• Neuroimaging
• Precision Psychiatry
• +۵ مورد دیگر

Nadine Parker is a Researcher at the Centre for Precision Psychiatry within the Faculty of Medicine at the University of Oslo. She is affiliated with Oslo University Hospital HF - Ullevål, Section for Precision Psychiatry, where she conducts cutting-edge research at the intersection of psychiatric genetics, neuroimaging, and precision medicine. Her work primarily focuses on understanding the genetic architecture of mental health disorders and their biological underpinnings. Dr. Parker's research interests center on psychiatric genetics, neuroimaging biomarkers, and precision psychiatry approaches. Her work explores the genetic overlap between various mental health conditions including depression, schizophrenia, bipolar disorder, and substance use disorders. She investigates how these disorders relate to physiological markers like white blood cell counts, inflammatory markers, and brain structure. Her research employs advanced genomic techniques including genome-wide association studies, polygenic risk scoring, and cross-disorder pleiotropy analysis to uncover shared biological mechanisms. Her publication record shows a strong focus on genetic architecture of psychiatric disorders, with numerous high-impact publications in journals like Nature Communications, Biological Psychiatry, and Molecular Psychiatry. Her work often examines how mental health conditions intersect with immune function, metabolic processes, and brain structure. A recurring theme across her publications is the identification of shared genetic mechanisms across seemingly distinct disorders, suggesting common biological pathways that could inform new treatment approaches. Dr. Parker is an active collaborator within the precision psychiatry research community, frequently working with colleagues including Guy Hindley, Alexey Shadrin, and other researchers at the University of Oslo. Her research is supported by institutional resources at Oslo University Hospital and likely external funding sources given the scale of her collaborative projects involving large datasets and international consortia. She is part of the Precision Psychiatry research group at Oslo University Hospital, which focuses on developing more targeted approaches to psychiatric diagnosis and treatment through integration of genetic, neuroimaging, and clinical data. This group works at the forefront of translating genetic discoveries into clinically actionable insights for mental health care.

Dagna Lorenzoمشاهده پروفایل

دانشیار

• Autoimmune Diseases
• Immunotherapy
• Autoinflammatory Diseases
• +۶ مورد دیگر

Dr. Dagna Lorenzo is an Associate Professor of Internal Medicine at Vita-Salute San Raffaele University School of Medicine in Milan, Italy, and Head of the Unit of Immunology, Rheumatology, Allergy, and Rare Diseases at IRCCS San Raffaele Scientific Institute. She holds leadership roles including Coordinator of the Clinical Immunology and Rheumatology Unit and Co-Director of the European School of Internal Medicine (ESIM). Her expertise spans over 25 years in clinical and translational research, with a focus on autoimmune/autoinflammatory diseases, immunotherapy, and the interplay between infections and immunity. Education : Medical Doctor (MD) summa cum laude from Università degli Studi di Milano; Board Certified in Internal Medicine from Vita-Salute San Raffaele University. Research Interests : Pathogenesis and treatment of autoimmune/autoinflammatory diseases, immune-related adverse effects of cancer immunotherapy, Erdheim-Chester disease mechanisms, herpesvirus-induced vasculitides, γδ T lymphocyte function, and apoptosis pathways in autoimmune lymphoproliferative syndrome. Publications (432+ articles): Recent work focuses on VEXAS syndrome (clonal dominance mechanisms), systemic sclerosis complications, and novel therapies for giant cell arteritis and Takayasu arteritis. Highlights include studies on FDG-PET imaging for vasculitis prognosis and Doppler ultrasound for mesenteric ischemia assessment. Awards : Fellow of the American College of Physicians (ACP), Honorary Fellow of the European Federation of Internal Medicine (EFIM). Grants & Teams : Leads multidisciplinary teams in rare diseases and chairs the EFIM Rare Disease Working Group. Collaborates internationally on initiatives like the Erdheim-Chester Global Alliance and the National Board of Medical Examiners (NBME). Labs/Teams : Directs the Immunology Unit at San Raffaele Scientific Institute, focusing on translational research bridging clinical practice and molecular mechanisms.

• Psychiatric Genetics
• Genomics
• Mental Health Disorders
• +۳ مورد دیگر

Dr. Daniel F. Levey is an Assistant Professor of Psychiatry at Yale University's School of Medicine. His research focuses on psychiatric genetics, particularly the genetic underpinnings of mental health disorders such as depression, post-traumatic stress disorder (PTSD), anxiety, and substance use disorders. He leads the Levey Lab, which employs genome-wide association studies (GWAS) and other genomic approaches to uncover biological mechanisms and inform therapeutic strategies. Levey holds a PhD in Medical Neuroscience from Indiana University and completed postdoctoral training at Yale. He has been recognized with awards including the NARSAD Young Investigator Award and the Million Veteran Program Early Career Investigator Award. His work leverages large-scale datasets like the Million Veteran Program and VA Biobank to study genetic risk factors and comorbidities. Key research areas include identifying genetic loci associated with PTSD, depression, cannabis use disorder, and insomnia, as well as exploring gene-environment interactions in mental health. He collaborates with institutions globally, contributing to studies on polygenic risk scores, drug repurposing for psychiatric conditions, and translational research. Levey's publications highlight discoveries such as novel PTSD risk loci, shared genetics between ADHD and cannabis use, and insights into depression's neurobiology. His lab actively investigates biomarkers for suicidality and integrates multi-omics data to advance precision medicine in psychiatry.